cystamine has been researched along with folic acid in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Gao, W; Wang, HY; Wang, YS; Zhang, P | 1 |
| Safarinejad, MR; Safarinejad, S; Shafiei, N | 1 |
| A, S; Ayyavu, M; Kandasamy, R; M, GA; S, AT | 1 |
| Jia, X; Li, J; Liu, P; Pei, M; Zhao, X | 1 |
| Ding, Y; Kang, Y; Lan, J; Lu, L; Yang, Y; Zhang, T; Zhang, X; Zhao, Y | 1 |
| Cai, H; He, Y; Li, F; Liu, Y; Wang, M; Xu, H; Zhao, Y | 1 |
6 other study(ies) available for cystamine and folic acid
| Article | Year |
|---|---|
Hyperhomocysteinemia and low plasma folate as risk factors for central retinal vein occlusion: a case-control study in a Chinese population.
Topics: Adult; Aged; Asian People; Case-Control Studies; China; Chromatography, High Pressure Liquid; Cross-Sectional Studies; Cystamine; Female; Folic Acid; Folic Acid Deficiency; Humans; Hyperhomocysteinemia; Male; Middle Aged; Radioimmunoassay; Retinal Vein Occlusion; Risk Factors | 2006 |
Relationship between three polymorphisms of methylenetetrahydrofolate reductase (MTHFR C677T, A1298C, and G1793A) gene and risk of prostate cancer: a case-control study.
Topics: Adult; Aged; Case-Control Studies; Cystamine; DNA; Folic Acid; Genetic Predisposition to Disease; Genetic Variation; Genotype; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Polymorphism, Single Nucleotide; Prostate-Specific Antigen; Prostatic Neoplasms; Vitamin B 12 | 2010 |
Synthesis and characterization of cystamine conjugated chitosan-SS-mPEG based 5-Fluorouracil loaded polymeric nanoparticles for redox responsive drug release.
Topics: Biological Transport; Cell Survival; Chemistry, Pharmaceutical; Chitosan; Cystamine; Drug Delivery Systems; Drug Liberation; Fluorouracil; Folic Acid; Humans; MCF-7 Cells; Nanoparticles; Oxidation-Reduction; Particle Size; Polyethylene Glycols; Surface Properties | 2018 |
Alginate-based cancer-associated, stimuli-driven and turn-on theranostic prodrug nanogel for cancer detection and treatment.
Topics: Alginates; Antineoplastic Agents; Cell Survival; Cystamine; Doxorubicin; Drug Liberation; Folic Acid; Folic Acid Transporters; Hep G2 Cells; Humans; Nanogels; Polyethylene Glycols; Polyethyleneimine; Prodrugs; Schiff Bases; Theranostic Nanomedicine | 2018 |
Reduction-sensitive CD44 receptor-targeted hyaluronic acid derivative micelles for doxorubicin delivery.
Topics: Animals; Cell Death; Cell Line, Tumor; Cell Survival; Cystamine; Doxorubicin; Drug Delivery Systems; Endocytosis; Folic Acid; Humans; Hyaluronan Receptors; Hyaluronic Acid; Male; Mice, Inbred BALB C; Mice, Nude; Micelles; Oxidation-Reduction; Particle Size; Polymers; Proton Magnetic Resonance Spectroscopy; Spectroscopy, Fourier Transform Infrared; Tissue Distribution | 2018 |
Nondestructive capture, release, and detection of circulating tumor cells with cystamine-mediated folic acid decorated magnetic nanospheres.
Topics: Cell Separation; Cystamine; Folic Acid; HEK293 Cells; HeLa Cells; Humans; Magnets; Nanospheres; Neoplasms; Neoplastic Cells, Circulating | 2020 |